Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-20-012175

VP, Clinical&Translational Sc sold 147 shares at $16.42 ($2,414)

  • VP, Clinical&Translational Sc acquired 575 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-12-18 Grant or award +575 62,258 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-12-21 Sale −147 $16.42 $2,414 62,111 D
Open-market sales · 147 sh · avg $16.42 · $2,414
Loading xslF345X03/edgar.xml…